Cempra, Inc.
CEMP
CEMP was delisted on the 3rd of November, 2017.
109 hedge funds and large institutions have $515M invested in Cempra, Inc. in 2014 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 27 increasing their positions, 25 reducing their positions, and 14 closing their positions.
200% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 14
183% more call options, than puts
Call options by funds: $13.3M | Put options by funds: $4.69M
133% more capital invested
Capital invested by funds: $221M → $515M (+$294M)
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
33% more funds holding
Funds holding: 82 → 109 (+27)
8% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$11.6M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
+$7.26M |
| 3 |
CPIM
Columbia Partners Investment Management
Alexandria,
Virginia
|
+$4.79M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$4.21M |
| 5 |
PA
Perceptive Advisors
New York
|
+$3.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.8M |
| 2 |
BC
Broadfin Capital
New York
|
-$10M |
| 3 |
PC
PointState Capital
New York
|
-$4.38M |
| 4 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$4.05M |
| 5 |
CGI
CI Global Investments
Oakland,
California
|
-$3.84M |
CEMP Hedge Fund Activity: Q4 2014 in Review
109 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Cempra, Inc. (CEMP) for Q4 2014, worth a combined $515M — up 133% from $221M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new CEMP positions and 14 closed out — a net gain of 28 holders — while 27 added to existing stakes and 25 trimmed.
The largest buyer was BB Biotech, opening a new position worth an estimated $11.6M. The largest seller was Fidelity Investments, cutting an estimated $10.8M.
- 109 institutional investors held Cempra, Inc. (CEMP) as of Q4 2014, up from 82 in Q3 2014.
- Funds reported $515M of Cempra, Inc. stock for Q4 2014, up 133% quarter-over-quarter.
- 42 funds opened new Cempra, Inc. positions in Q4 2014 and 14 closed out, a net change of +28 holders.
- The largest Cempra, Inc. buyer in Q4 2014 was BB Biotech, an estimated $11.6M added.
- The largest Cempra, Inc. seller in Q4 2014 was Fidelity Investments, an estimated $10.8M sold.
Based on aggregated 13F filings for Q4 2014.